BP-lowering drugs reduced major CV events by similar amounts in patients with and without type 2 diabetes.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 36469918.
- Also identified by DOI 10.7326/J22-0093.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nazarzadeh M, Bidel Z, Canoy D, et al. <b>Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.</b> Lancet Diabetes Endocrinol. 2022;10:645-54. 35878651.
Medical subject headings
- Cardiovascular Diseases
- Diabetes Mellitus, Type 2
- Hypertension